Literature DB >> 33905960

Effect of tissue microenvironment on fibrous capsule formation to biomaterial-coated implants.

Jamie L Hernandez1, Jaehyung Park1, Shan Yao2, Anna K Blakney1, Hienschi V Nguyen1, Bob H Katz3, Jeffrey T Jensen2, Kim A Woodrow4.   

Abstract

Within tissue exposed to the systemic immune system, lymphocytes and fibroblasts act against biomaterials via the development of a fibrous capsule, known as the foreign body reaction (FBR). Inspired by the natural tolerance that the uterine cavity has to foreign bodies, our study explores the role of microenvironment across classical (subcutaneous) and immune privileged (uterine) tissues in the development of the FBR. As a model biomaterial, we used electrospun fibers loaded with sclerosing agents to provoke scar tissue growth. Additionally, we integrated these materials onto an intrauterine device as a platform for intrauterine biomaterial studies. Polyester materials in vitro achieved drug release up to 10 days, greater pro-inflammatory and pro-healing cytokine expression, and the addition of gelatin enabled greater fibroblast attachment. We observed the materials that induced the greatest FBR in the mouse, had no effect when inserted at the utero-tubal junction of non-human primates. These results suggest that the FBR varies across different tissue microenvironments, and a dampened fibrotic response exists in the uterine cavity, possibly due to immune privilege. Further study of immune privileged tissue factors on biomaterials could broaden our understanding of the FBR and inform new methods for achieving biocompatibility in vivo.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Electrospun fibers; Female reproductive tract; Foreign body reaction; Immune privilege; Intrauterine device; Sclerosing agents

Year:  2021        PMID: 33905960     DOI: 10.1016/j.biomaterials.2021.120806

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Mercaptopurine-Loaded Sandwiched Tri-Layered Composed of Electrospun Polycaprolactone/Poly(Methyl Methacrylate) Nanofibrous Scaffolds as Anticancer Carrier with Antimicrobial and Antibiotic Features: Sandwich Configuration Nanofibers, Release Study and in vitro Bioevaluation Tests.

Authors:  Samar A Salim; Elbadawy A Kamoun; Stephen Evans; Shahira H El-Moslamy; Esmail M El-Fakharany; Mohamed M Elmazar; A F Abdel-Aziz; R H Abou-Saleh; Taher A Salaheldin
Journal:  Int J Nanomedicine       Date:  2021-10-11

Review 2.  Medical Applications of Porous Biomaterials: Features of Porosity and Tissue-Specific Implications for Biocompatibility.

Authors:  Jamie L Hernandez; Kim A Woodrow
Journal:  Adv Healthc Mater       Date:  2022-02-19       Impact factor: 11.092

Review 3.  Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity.

Authors:  Themis R Kyriakides; Hyun-Je Kim; Christy Zheng; Lauren Harkins; Wanyun Tao; Emily Deschenes
Journal:  Biomed Mater       Date:  2022-03-04       Impact factor: 4.103

4.  3D cell-printing of gradient multi-tissue interfaces for rotator cuff regeneration.

Authors:  Suhun Chae; Uijung Yong; Wonbin Park; Yoo-Mi Choi; In-Ho Jeon; Homan Kang; Jinah Jang; Hak Soo Choi; Dong-Woo Cho
Journal:  Bioact Mater       Date:  2022-05-11

Review 5.  3D Printed Multiphasic Scaffolds for Osteochondral Repair: Challenges and Opportunities.

Authors:  Stephanie E Doyle; Finn Snow; Serena Duchi; Cathal D O'Connell; Carmine Onofrillo; Claudia Di Bella; Elena Pirogova
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

6.  Drug Eluting Embolization Particles for Permanent Contraception.

Authors:  Hannah VanBenschoten; Shan Yao; Jeffrey T Jensen; Kim A Woodrow
Journal:  ACS Biomater Sci Eng       Date:  2022-06-24

Review 7.  Advanced strategies to thwart foreign body response to implantable devices.

Authors:  Simone Capuani; Gulsah Malgir; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Bioeng Transl Med       Date:  2022-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.